• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 介导的肝损伤中的年龄依赖性免疫反应:聚焦细胞因子。

Age-dependent immune responses in COVID-19-mediated liver injury: focus on cytokines.

机构信息

Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Department of Immunology, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.

出版信息

Front Endocrinol (Lausanne). 2023 Aug 15;14:1139692. doi: 10.3389/fendo.2023.1139692. eCollection 2023.

DOI:10.3389/fendo.2023.1139692
PMID:37654571
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10465349/
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is potentially pathogenic and causes severe symptoms; in addition to respiratory syndromes, patients might experience other severe conditions such as digestive complications and liver complications injury. The abnormality in the liver is manifested by hepatobiliary dysfunction and enzymatic elevation, which is associated with morbidity and mortality. The direct cytopathic effect, immune dysfunction, cytokine storm, and adverse effects of therapeutic regimens have a crucial role in the severity of liver injury. According to aging and immune system alterations, cytokine patterns may also change in the elderly. Moreover, hyperproduction of cytokines in the inflammatory response to SARS-CoV-2 can lead to multi-organ dysfunction. The mortality rate in elderly patients, particularly those with other comorbidities, is also higher than in adults. Although the pathogenic effect of SARS-CoV-2 on the liver has been widely studied, the impact of age and immune-mediated responses at different ages remain unclear. This review discusses the association between immune system responses in coronavirus disease 2019 (COVID-19) patients of different ages and liver injury, focusing on cytokine alterations.

摘要

严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)具有潜在的致病性,并导致严重症状;除了呼吸道综合征外,患者还可能出现其他严重情况,如消化并发症和肝损伤。肝脏的异常表现为肝胆功能障碍和酶升高,这与发病率和死亡率有关。直接细胞病变作用、免疫功能障碍、细胞因子风暴以及治疗方案的不良反应在肝损伤的严重程度中起着关键作用。根据年龄和免疫系统的改变,细胞因子模式也可能在老年人中发生变化。此外,SARS-CoV-2 炎症反应中细胞因子的过度产生可导致多器官功能障碍。老年患者,特别是有其他合并症的患者,死亡率也高于成年人。虽然 SARS-CoV-2 对肝脏的致病作用已被广泛研究,但不同年龄的免疫系统反应和免疫介导反应的影响尚不清楚。本综述讨论了不同年龄 COVID-19 患者的免疫系统反应与肝损伤之间的关系,重点讨论了细胞因子的改变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07af/10465349/9ee012ff10e2/fendo-14-1139692-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07af/10465349/b9f088871aaa/fendo-14-1139692-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07af/10465349/9ee012ff10e2/fendo-14-1139692-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07af/10465349/b9f088871aaa/fendo-14-1139692-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07af/10465349/9ee012ff10e2/fendo-14-1139692-g002.jpg

相似文献

1
Age-dependent immune responses in COVID-19-mediated liver injury: focus on cytokines.COVID-19 介导的肝损伤中的年龄依赖性免疫反应:聚焦细胞因子。
Front Endocrinol (Lausanne). 2023 Aug 15;14:1139692. doi: 10.3389/fendo.2023.1139692. eCollection 2023.
2
Do inflammaging and coagul-aging play a role as conditions contributing to the co-occurrence of the severe hyper-inflammatory state and deadly coagulopathy during COVID-19 in older people?炎症衰老和凝血衰老是否在导致 COVID-19 老年人中严重炎症状态和致命性凝血障碍同时发生的条件中起作用?
Exp Gerontol. 2021 Aug;151:111423. doi: 10.1016/j.exger.2021.111423. Epub 2021 May 26.
3
An enlightening role for cytokine storm in coronavirus infection.细胞因子风暴在冠状病毒感染中的启示作用。
Clin Immunol. 2021 Jan;222:108615. doi: 10.1016/j.clim.2020.108615. Epub 2020 Oct 23.
4
The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of "inflame-aging".COVID-19 感染老年患者细胞因子风暴的可能病理生理学机制:“炎症性衰老”的作用。
Inflamm Res. 2020 Sep;69(9):825-839. doi: 10.1007/s00011-020-01372-8. Epub 2020 Jun 11.
5
Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy.严重 COVID-19 中失调的干扰素反应和免疫过度激活:靶向 STATs 作为一种新的治疗策略。
Front Immunol. 2022 May 17;13:888897. doi: 10.3389/fimmu.2022.888897. eCollection 2022.
6
Systems Immunology Analysis Reveals the Contribution of Pulmonary and Extrapulmonary Tissues to the Immunopathogenesis of Severe COVID-19 Patients.系统免疫分析揭示了肺和肺外组织对重症 COVID-19 患者免疫发病机制的贡献。
Front Immunol. 2021 Jun 28;12:595150. doi: 10.3389/fimmu.2021.595150. eCollection 2021.
7
The Role of Inflammatory Cytokines (Interleukin-1 and Interleukin-6) as a Potential Biomarker in the Different Stages of COVID-19 (Mild, Severe, and Critical).炎症细胞因子(白细胞介素-1 和白细胞介素-6)在 COVID-19(轻症、重症和危重症)不同阶段作为潜在生物标志物的作用。
J Interferon Cytokine Res. 2023 Apr;43(4):147-163. doi: 10.1089/jir.2022.0185.
8
Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts.细胞因子风暴和白细胞变化在轻度和重度 SARS-CoV-2 感染中的表现:对中国 3939 例 COVID-19 患者的回顾,以及新出现的发病机制和治疗概念。
J Leukoc Biol. 2020 Jul;108(1):17-41. doi: 10.1002/JLB.3COVR0520-272R. Epub 2020 Jun 13.
9
Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.新冠病毒肺炎患者细胞因子风暴及细胞因子靶向治疗的危害:综述
J Med Internet Res. 2020 Aug 13;22(8):e20193. doi: 10.2196/20193.
10
Unraveling the Molecular and Cellular Pathogenesis of COVID-19-Associated Liver Injury.解析 COVID-19 相关肝损伤的分子和细胞发病机制。
Viruses. 2023 May 30;15(6):1287. doi: 10.3390/v15061287.

引用本文的文献

1
Landscape of infiltrated immune cell characterization in COVID-19.新型冠状病毒肺炎中浸润性免疫细胞特征图谱
Heliyon. 2024 Mar 18;10(6):e28174. doi: 10.1016/j.heliyon.2024.e28174. eCollection 2024 Mar 30.
2
Secondary infections and long-term outcomes among hospitalized elderly and non-elderly patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and treated with baricitinib: a comparative study from the national centre of Hungary.住院的老年和非老年严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 患者接受巴瑞替尼治疗后的继发感染和长期结局:来自匈牙利国家中心的一项比较研究。
Geroscience. 2024 Jun;46(3):2863-2877. doi: 10.1007/s11357-024-01099-y. Epub 2024 Feb 17.
3

本文引用的文献

1
Liver injury induced by COVID 19 treatment - what do we know?新冠病毒治疗导致的肝损伤——我们了解多少?
World J Gastroenterol. 2022 Dec 7;28(45):6314-6327. doi: 10.3748/wjg.v28.i45.6314.
2
Autoimmune hepatitis following COVID-19 vaccination.新冠病毒疫苗接种后发生的自身免疫性肝炎。
J Autoimmun. 2022 Oct;132:102874. doi: 10.1016/j.jaut.2022.102874. Epub 2022 Aug 5.
3
COVID-19 and liver disease.COVID-19 与肝病。
Single-Cell RNA Sequencing Reveals Alterations in Patient Immune Cells with Pulmonary Long COVID-19 Complications.
单细胞RNA测序揭示了患有肺部长期新冠并发症患者免疫细胞的改变。
Curr Issues Mol Biol. 2024 Jan 2;46(1):461-468. doi: 10.3390/cimb46010029.
4
Increased Expression of lncRNA AC000120.7 and SENP3-EIF4A1 in Patients with Acute Respiratory Distress Syndrome Induced by SARS-CoV-2 Infection: A Pilot Study.SARS-CoV-2感染所致急性呼吸窘迫综合征患者lncRNA AC000120.7和SENP3-EIF4A1的表达增加:一项初步研究
Microorganisms. 2023 Sep 19;11(9):2342. doi: 10.3390/microorganisms11092342.
Gut. 2022 Nov;71(11):2350-2362. doi: 10.1136/gutjnl-2021-326792. Epub 2022 Jun 14.
4
Long COVID-19 Liver Manifestation in Children.儿童长新冠肝脏表现。
J Pediatr Gastroenterol Nutr. 2022 Sep 1;75(3):244-251. doi: 10.1097/MPG.0000000000003521. Epub 2022 Aug 9.
5
Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcome.新型冠状病毒疫苗接种后的肝损伤:免疫介导性肝炎的特征、皮质类固醇治疗的作用和转归。
Hepatology. 2022 Dec;76(6):1576-1586. doi: 10.1002/hep.32572. Epub 2022 Jun 23.
6
Autoimmune Hepatitis-Like Syndrome Following COVID-19 Vaccination: A Systematic Review of the Literature.接种 COVID-19 疫苗后出现的自身免疫性肝炎样综合征:文献系统评价。
Dig Dis Sci. 2022 Sep;67(9):4574-4580. doi: 10.1007/s10620-022-07504-w. Epub 2022 Apr 29.
7
Age-adjusted mortality and predictive value of liver chemistries in a Viennese cohort of COVID-19 patients.维也纳队列中 COVID-19 患者的年龄调整死亡率和肝功能指标的预测价值。
Liver Int. 2022 Jun;42(6):1297-1307. doi: 10.1111/liv.15274. Epub 2022 May 5.
8
COVID-19 and liver disease: where are we now?COVID-19 与肝脏疾病:我们现在处于什么阶段?
Nat Rev Gastroenterol Hepatol. 2022 May;19(5):277-278. doi: 10.1038/s41575-022-00607-9.
9
The immunology and immunopathology of COVID-19.新型冠状病毒肺炎的免疫学和免疫病理学。
Science. 2022 Mar 11;375(6585):1122-1127. doi: 10.1126/science.abm8108. Epub 2022 Mar 10.
10
Interleukin-8: An evolving chemokine.白细胞介素-8:一种不断演变的趋化因子。
Cytokine. 2022 May;153:155828. doi: 10.1016/j.cyto.2022.155828. Epub 2022 Mar 2.